JAMIE LITTLE: Open Payments
NPI 1871249581 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$533 in 29 payments from 12 companies in 2025. Trend: 2023 $535 · 2024 $552 · 2025 $533
Food & beverage: $533
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $159 |
| Sumitomo Pharma America, Inc. | 3 | $57 |
| Lilly USA, LLC | 3 | $53 |
| ABBVIE INC. | 2 | $43 |
| Dexcom, Inc. | 2 | $37 |
| Merck Sharp & Dohme LLC | 2 | $31 |
| Novo Nordisk Inc | 2 | $30 |
| GlaxoSmithKline, LLC. | 1 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $28 |
| AstraZeneca Pharmaceuticals LP | 2 | $27 |
Products named: XIFAXAN, GEMTESA, Dexcom G6 Transmitter, KISUNLA, CAPVAXIVE, Wegovy, AREXVY, LINZESS.
Industry payments across LA — which companies pay providers there.
